Next Article in Journal
Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions
Previous Article in Journal
Molecular Dynamics Simulations Suggest a Non-Doublet Decoding Model of −1 Frameshifting by tRNASer3
Previous Article in Special Issue
Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature
Open AccessArticle

Investigating the Systems-Level Effect of Pueraria lobata for Menopause-Related Metabolic Diseases Using an Ovariectomized Rat Model and Network Pharmacological Analysis

1
Department of Physiology, College of Korean Medicine, Gachon University, Seongnam 13120, Korea
2
Department of Obstetrics and Gynecology, College of Korean Medicine, Daejeon University, Daejeon 35235, Korea
3
Department of Preventive Medicine, College of Korean Medicine, Gachon University, Seongnam 13120, Korea
4
Department of Food Science, Gyeongnam National University of Science and Technology, Jinju 52725, Korea
5
Department of Pediatrics, College of Korean Medicine, Daejeon University, Daejeon 35235, Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomolecules 2019, 9(11), 747; https://doi.org/10.3390/biom9110747
Received: 6 September 2019 / Revised: 5 November 2019 / Accepted: 14 November 2019 / Published: 18 November 2019
This study was conducted to evaluate the biological activities of Pueraria lobata (PL) on menopause-related metabolic diseases and to explore the underlying mechanism of PL by network pharmacological analyses. We used ovariectomized (OVX) rats as a postmenopausal model and administered PL at different doses (50, 100, and 200 mg/kg). In OVX rats, decreased uterine weights and PPAR-γ (peroxisome proliferator-activated receptor-gamma) mRNA expression in the thigh muscle were significantly recovered after PL administration. PL also significantly alleviated OVX-induced increases in total cholesterol, triglyceride, alanine aminotransferase (ALT/GPT), and aspartate aminotransferase (AST/GOT) levels. To identify the systems-level mechanism of PL, we performed network pharmacological analyses by predicting the targets of the potential bioactive compounds and their associated pathways. We identified 61 targets from four potential active compounds of PL: formononetin, beta-sitosterol, 3’-methoxydaidzein, and daidzein-4,7-diglucoside. Pathway enrichment analysis revealed that among female sex hormone-related pathways, the estrogen signaling pathways, progesterone-mediated oocyte maturation, oxytocin signaling pathways, and prolactin signaling pathways were associated with multiple targets of PL. In conclusion, we found that PL improved various indicators associated with lipid metabolism in the postmenopausal animal model, and we also identified that its therapeutic effects are exerted via multiple female sex hormone-related pathways. View Full-Text
Keywords: menopause-related metabolic diseases; menopause; Pueraria lobata; network pharmacology; lipid metabolism; dyslipidemia menopause-related metabolic diseases; menopause; Pueraria lobata; network pharmacology; lipid metabolism; dyslipidemia
Show Figures

Figure 1

MDPI and ACS Style

Oh, J.H.; Baek, S.-E.; Lee, W.-Y.; Baek, J.Y.; Trinh, T.A.; Park, D.H.; Lee, H.L.; Kang, K.S.; Kim, C.-E.; Yoo, J.-E. Investigating the Systems-Level Effect of Pueraria lobata for Menopause-Related Metabolic Diseases Using an Ovariectomized Rat Model and Network Pharmacological Analysis. Biomolecules 2019, 9, 747.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop